Assembly Biosciences (ASMB) Revenue & Revenue Breakdown
Assembly Biosciences Revenue Highlights
0
Latest Revenue (Q)
$9.42M
Assembly Biosciences Revenue by Period
Assembly Biosciences Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | - | -100.00% |
| 2023-12-31 | $7.16M | 100.00% |
| 2022-12-31 | - | -100.00% |
| 2021-12-31 | $6.25M | -92.09% |
| 2020-12-31 | $79.11M | 395.55% |
| 2019-12-31 | $15.96M | 7.83% |
| 2018-12-31 | $14.80M | 64.15% |
| 2017-12-31 | $9.02M | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2012-12-31 | - | 100.00% |
| 2011-12-31 | - | 100.00% |
| 2010-12-31 | - | 100.00% |
| 2009-12-31 | - | 100.00% |
| 2008-12-31 | - | - |
Assembly Biosciences generated - in revenue during NA 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Assembly Biosciences Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-03-31 | $9.42M | 28.03% |
| 2024-12-31 | $7.36M | 7.48% |
| 2024-09-30 | $6.84M | -19.78% |
| 2024-06-30 | $8.53M | 47.50% |
| 2024-03-31 | $5.79M | -19.24% |
| 2023-12-31 | $7.16M | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | -100.00% |
| 2021-09-30 | $6.25M | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | -100.00% |
| 2020-12-31 | $1.04M | -97.00% |
| 2020-09-30 | $34.61M | -12.10% |
| 2020-06-30 | $39.38M | 864.86% |
| 2020-03-31 | $4.08M | -14.37% |
| 2019-12-31 | $4.77M | 12.64% |
| 2019-09-30 | $4.23M | 37.37% |
| 2019-06-30 | $3.08M | -20.72% |
| 2019-03-31 | $3.88M | 4.01% |
| 2018-12-31 | $3.74M | -12.85% |
| 2018-09-30 | $4.29M | 33.19% |
| 2018-06-30 | $3.22M | -9.74% |
| 2018-03-31 | $3.57M | 7.53% |
| 2017-12-31 | $3.32M | 24.66% |
| 2017-09-30 | $2.66M | 12.73% |
| 2017-06-30 | $2.36M | 244.74% |
| 2017-03-31 | $684.37K | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-06-30 | - | 100.00% |
| 2014-03-31 | - | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2013-09-30 | - | 100.00% |
| 2013-06-30 | - | 100.00% |
| 2013-03-31 | - | 100.00% |
| 2012-12-31 | - | 100.00% |
| 2012-09-30 | - | 100.00% |
| 2012-06-30 | - | 100.00% |
| 2012-03-31 | - | 100.00% |
| 2011-12-31 | - | 100.00% |
| 2011-09-30 | - | 100.00% |
| 2011-06-30 | - | 100.00% |
| 2011-03-31 | - | 100.00% |
| 2010-12-31 | - | 100.00% |
| 2010-09-30 | - | 100.00% |
| 2010-06-30 | - | 100.00% |
| 2010-03-31 | - | 100.00% |
| 2009-12-31 | - | 100.00% |
| 2009-09-30 | - | 100.00% |
| 2009-06-30 | - | 100.00% |
| 2009-03-31 | - | - |
Assembly Biosciences generated $9.42M in revenue during Q1 2025, up 28.03% compared to the previous quarter, and up 131.50% compared to the same period a year ago.
Assembly Biosciences Revenue Breakdown
Assembly Biosciences Revenue Breakdown by Product
Quarterly Revenue by Product
| Product/Service | Sep 18 | Jun 18 |
|---|---|---|
| License and Service | $1.20M | $1.20M |
Latest
Assembly Biosciences's latest quarterly revenue breakdown by segment (product or service), as of Sep 18: License and Service (100.00%).
Assembly Biosciences Revenue Breakdown by Country
Quarterly Revenue by Country
| Country | Sep 18 | Jun 18 |
|---|---|---|
| License and Service | $1.20M | $1.20M |
Latest
Assembly Biosciences's latest quarterly revenue breakdown by geography, as of Sep 18: License and Service (100.00%).
Assembly Biosciences Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| SGMO | Sangamo Therapeutics | $57.80M | $6.44M |
| GNFT | Genfit | $28.57M | $17.08M |
| NTHI | Neonc Technologies | $83.00K | - |
| IMRX | Immuneering | - | - |
| ZURA | Zura Bio | - | - |
| SLS | SELLAS Life Sciences Group | - | - |
| EPRX | Eupraxia Pharmaceuticals | - | - |
| TARA | Protara Therapeutics | - | - |
| ASMB | Assembly Biosciences | - | $9.42M |
| SAVA | Cassava Sciences | - | - |
| SGMT | Sagimet Biosciences | - | - |